Lack of DMBT1 expression in oesophageal, gastric and colon cancers

British Journal of Cancer

Volumn 79, Issue 2, 1999, Pages 211-213

  Mori, M ^a   Shiraishi, T ^a   Tanaka, S ^a   Yamagata, M ^a   Mafune, K ^b   Tanaka, Y ^c   Ueo, H ^d   Barnard, G F ^e   Sugimachi, K ^f  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SAITAMA CANCER CENTER   (Japan)

^d OITA PREFECTURAL HOSPITAL   (Japan)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f KYUSHU UNIVERSITY   (Japan)

Author keywords

DMBT1 gene; Gastrointestinal cancer; Homozygous deletion; Oesophageal cancer; Tumour suppressor gene

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 10Q; COLON CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

EID: 0032893305     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690035     Document Type: Article

References (13)

1. Albarosa R, Colombo BM, Roz L, Magnani I, Pollo B, Cirenei N, Giani C, Conti AM, DiDonato S and Finocchiaro G (1996) Deletion mapping of gliomas suggests the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q. Am J Hum Genet 58: 1260-1267
2. Aoki T, Mori T, Du XO, Nishihira T, Matsubara T and Nakamura Y (1994) Allelotype study of esophageal carcinoma. Genes Chroms Cancer 10: 177-182
3. Gray IC, Phillips SM, Lee SJ, Neoptolemos JP, Weissenbach J and Spurr NK (1995) Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 55: 4800-4803
4. Hahn SA, Seymour AB, Hoque ATMS, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE (1995) Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 55: 4670-4675
5. Herbst R, Weiss J, Ehnis A, Cavence WK and Arden KC (1995) Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res 54: 3111-3114
6. Kong D, Suzuki A, Zou TT, Sakurada A, Kemp LW, Wakatsuki S, Yokoyama T, Yamakawa H, Furukawa T, Sato S, Yin J, Wang S, Abrahan JM, Souza RF, Smolinski KN, Meltzer SJ and Horii A (1997) PTENI is frequently mutated in primary endometrial carcinomas. Nature Genet 17: 143-144
7. Li J, Mori M, Yang Y, Inoue H, Mimori K, Shibuta K, Nakashima H, Mafune K, Shimada Y, Barnard GF, Sugimachi K and Akiyoshi T (1995) Multiple tumor suppressor 1 gene and esophageal carcinoma. Int J Cancer 7: 257-260
8. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Iumann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947
9. Mollenhauer J, Wiemann S, Seheurlen W, Korn B, Hayashi Y, Wilgenbus K, von Deimling A and Poustka A (1997) DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumors. Nature Genet 17: 32-39
10. Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, Ueo H and Akiyoshi T (1995) Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 55: 3417-3420
11. Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, Sugimachi K and Akiyoshi T (1998) Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 16: 128-132
12. Peiffer SL, Herzog TJ, Tribune DJ, Mutch DG, Gersell DJ and Goodfellow PJ (1995) Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res 54: 1922-1926
13. Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, Reichel MB, Ried T and Dietel M (1997) Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q, and 17p. Br J Cancer 75: 79-86